Medical researchers documented growing clinical evidence that Staphylococcus aureus strains were developing resistance to penicillin at an alarming rate within hospital wards, barely a decade after the drug's wartime triumph. The findings offered an early warning of a problem that would grow into one of medicine's most pressing challenges: the evolution of drug-resistant 'superbugs.'
Penicillin had seemed almost miraculous when it reached widespread use in the 1940s, curing infections that had killed soldiers and civilians for millennia. But bacteria evolve fast, and hospitals—full of sick patients and heavy antibiotic use—turned out to be perfect laboratories for natural selection to favor resistant strains.
By the mid-1950s, physicians were reporting staphylococcus infections that simply would not respond to penicillin doses that once cured them easily. Alexander Fleming himself, who had discovered penicillin, had warned as early as his 1945 Nobel lecture that misuse of the drug could breed resistant organisms, and events were already proving him right.
The crisis would only deepen over the following decades, driving pharmaceutical research toward new antibiotic classes—methicillin, vancomycin, and beyond—each eventually met by new resistant strains, a biological arms race with no permanent winner in sight.